Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis.

NCT06308445 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT06308445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06308445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis.
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 30, 2030
Enrollment
25 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

familial adenomatous polyposis